Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Introduction of a Quick Assay for ADAMTS13 Activity Improved a Survival of Acquired TTP Patients Who Received Platelet Transfusions

Yumi Yoshii, MD, Masanori Matsumoto, MD PhD, Kurumatani Norio, MD PhD, Ayami Isonishi, BS, Masahito Uemura, MD PhD, Yuji Hori, PhD, Masaki Hayakawa, MD, Hideo Yagi, MD PhD, Charles L Bennett, MD PhD MPP, Yoshihiro Fujimura, MD PhD

Blood (2014) 124 (21): 4209.

https://doi.org/10.1182/blood.V124.21.4209.4209

Published: 2014

Journal Articles

A Long-Term Phenotype Analysis Of 51 Patients With Upshaw–Schulman Syndrome In Japan, With Special References To Pregnancy and Renal Failure That Requires Hemodialysis

Yoshihiro Fujimura, MD, PhD, Yumi Yoshii, MD, Masanori Matsumoto, MD, PhD, Ayami Isonishi, BS, Masaki Hayakawa, MD, Yoko Yoshida, MS, Hideo Yagi, MD, PhD, Koichi Kokame, PhD, Toshiyuki Miyata, PhD

Blood (2013) 122 (21): 3545.

https://doi.org/10.1182/blood.V122.21.3545.3545

Published: 2013

Journal Articles

Anti-ADAMTS13 Inhibitor Boosting During Plasma Exchange Therapy Often Causes an Intractable Acquired Idiopathic TTP

Ayami Isonishi, BS, Masanori Matsumoto, MD, PhD, Friedrich Scheiflinger, PhD, Barbara Plaimauer, PhD, Charles Bennett, MD, PhD, MPP, Yoshihiro Fujimura, MD, PhD

Blood (2012) 120 (21): 1086.

https://doi.org/10.1182/blood.V120.21.1086.1086

Published: 2012

Journal Articles

A Large-Pore IEF Gel Electrophoresis Separates the Complex in Both of ADAMTS13 Bound to VWF and to the IgG Autoantibodies From the Unbound in Plasma Milieu

Masanori Matsumoto, MD, PhD, Ayami Isonishi, BS, Yuji Hori, BS, Masaki Hayakawa, MD, Kenji Soejima, PhD, Yoshihiro Fujimura, MD, PhD

Blood (2011) 118 (21): 1160.

https://doi.org/10.1182/blood.V118.21.1160.1160

Published: 2011

Journal Articles

Characterization of Two Patient Groups with Acquired Idiopathic Thrombotic Thrombocytopenic Purpura, Defined by ADAMTS13 (n=195) and/or Classic Pentad (n=89).

Masanori Matsumoto, MD, Ayami Isonishi, BS, Seiji Kato, PhD, Hiromichi Ishizashi, PhD, Hideo Yagi, MD, Yoshihiro Fujimura, MD

Blood (2009) 114 (22): 3505.

https://doi.org/10.1182/blood.V114.22.3505.3505

Published: 2009

NARROW

Introduction of a Quick Assay for ADAMTS13 Activity Improved a Survival of Acquired TTP Patients Who Received Platelet Transfusions

A Long-Term Phenotype Analysis Of 51 Patients With Upshaw–Schulman Syndrome In Japan, With Special References To Pregnancy and Renal Failure That Requires Hemodialysis

Anti-ADAMTS13 Inhibitor Boosting During Plasma Exchange Therapy Often Causes an Intractable Acquired Idiopathic TTP

A Large-Pore IEF Gel Electrophoresis Separates the Complex in Both of ADAMTS13 Bound to VWF and to the IgG Autoantibodies From the Unbound in Plasma Milieu

Characterization of Two Patient Groups with Acquired Idiopathic Thrombotic Thrombocytopenic Purpura, Defined by ADAMTS13 (n=195) and/or Classic Pentad (n=89).

Email alerts

ASH Publications

American Society of Hematology

Introduction of a Quick Assay for ADAMTS13 Activity Improved a Survival of Acquired TTP Patients Who Received Platelet Transfusions

A Long-Term Phenotype Analysis Of 51 Patients With Upshaw–Schulman Syndrome In Japan, With Special References To Pregnancy and Renal Failure That Requires Hemodialysis

Anti-ADAMTS13 Inhibitor Boosting During Plasma Exchange Therapy Often Causes an Intractable Acquired Idiopathic TTP

A Large-Pore IEF Gel Electrophoresis Separates the Complex in Both of ADAMTS13 Bound to VWF and to the IgG Autoantibodies From the Unbound in Plasma Milieu

Characterization of Two Patient Groups with Acquired Idiopathic Thrombotic Thrombocytopenic Purpura, Defined by ADAMTS13 (n=195) and/or Classic Pentad (n=89).

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only